IPP Bureau
USFDA grants Priority Review for new indication of finerenone for patients with common heart failure
By IPP Bureau - March 20, 2025
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
By IPP Bureau - March 20, 2025
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
ZIM Laboratories receives marketing authorization for Dimethyl Fumarate in Portugal
By IPP Bureau - March 20, 2025
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Briefs: Dr. Agarwal's Eye Hospital and Apitoria Pharma
By IPP Bureau - March 20, 2025
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Healthcare Triangle appoints Sujatha Ramesh as COO
By IPP Bureau - March 20, 2025
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Entero launches ‘HealthEdge’ programme to empower Retail Chemists
By IPP Bureau - March 20, 2025
UFlex’s FlexiTubes to showcase sustainable beauty packaging at COSMOPROF Italy 2025
By IPP Bureau - March 20, 2025
FlexiTubes will showcase range of eco-friendly and innovative tube options
Aerogen opens India HQ in New Delhi
By IPP Bureau - March 20, 2025
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Croda opens advanced lipids manufacturing facility in Pennsylvania
By IPP Bureau - March 19, 2025
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Financial Times names Indegene among high-growth companies in Asia-Pacific 2025
By IPP Bureau - March 19, 2025
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
By IPP Bureau - March 19, 2025
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
Anupriya Patel inaugurates India Innovation Summit – Pioneering Solutions to End TB
By IPP Bureau - March 19, 2025
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Clariant unveils natural preservation blend for cosmetics 'Nipaguard SCE Vita'
By IPP Bureau - March 19, 2025
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
By IPP Bureau - March 19, 2025
Alkem Medtech to acquire 100% stake of Bombay Ortho
RedHill Biopharma to submit FDA-approved Talicia for UK marketing authorisation
By IPP Bureau - March 19, 2025
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
